Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Computer Motion plans third quarter launch for voice-controlled surgical robot.

This article was originally published in The Gray Sheet

Executive Summary

COMPUTER MOTION INC. TO BEGIN SHIPPING VOICE-CONTROLLED SURGICAL ROBOT IN 3RD Q of 1996, according to the company. CMI gained 510(k) clearance for the AESOP 2000 (Automated Endoscopic System for Opimal Positioning) device on May 3 and expects to begin commercial shipments following completion of preliminary market testing. The system positions the laparoscope in response to a surgeon's voice commands during minimally invasive surgery.

You may also be interested in...



Vanda Comes Up Empty Handed As US Supreme Court Denies Hetlioz Appeal

Vanda looks likely to have to face up to unimpeded US generic competition to its core Hetlioz brand, after a further denial in its litigation against ANDA sponsors Teva and Apotex.

EU: Good News For IVDs And For Future Transparency Of Medtech Compliance

The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel